The heart and vascular system in dialysis

Christoph Wanner1, Kerstin Amann2, Tetsuo Shoji3

  • 1Comprehensive Heart Failure Center and Renal Division, University Hospital of Würzburg, Würzburg, Germany.

PubMed

Insights

Kidney disease accelerates heart and vascular aging, leading to significant cardiac dysfunction and increased mortality in dialysis patients. New large trials are needed for effective cardioprotective strategies during renal replacement therapy.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Kidney function decline and renal replacement therapy (RRT) precipitate major cardiovascular changes.
  • Patients on RRT exhibit accelerated cardiovascular aging, including left ventricular hypertrophy, dysfunction, fibrosis, and vascular disease (atherosclerosis, arteriosclerosis).
  • Fluid overload and hypertension are primary drivers of cardiac issues, while intradialytic stress exacerbates cardiac arrest risk.

Purpose of the Study:

  • To summarize the cardiovascular structural and functional changes in patients with declining kidney function requiring RRT.
  • To highlight the accelerated aging phenotype and increased cardiac/vascular mortality in this population.
  • To emphasize the limitations of current pharmacological interventions and the need for large cardioprotective trials.

Main Methods:

  • Review of cardiovascular changes associated with kidney disease and RRT.
  • Analysis of risk factors including fluid overload, hypertension, and intradialytic stress.
  • Evaluation of existing trial limitations regarding pharmacological interventions.

Main Results:

  • Significant left ventricular hypertrophy, dilatation, systolic/diastolic dysfunction, and myocardial fibrosis are prevalent.
  • Vascular tree affected by atherosclerosis and arteriosclerosis, with media calcification.
  • Cardiac and vascular mortality rates are substantially elevated compared to the general population, particularly in younger patients.

Conclusions:

  • Cardiovascular disease in RRT patients mimics accelerated aging and latent heart failure.
  • Current pharmacological interventions (e.g., statins) show limitations.
  • Large, pragmatic trials focusing on cardio-active interventions are essential for effective cardioprotection in RRT.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.9K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.6K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.9K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.1K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.4K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K